Comparison of bleeding risks among non-vitamin K antagonist oral anticoagulants using the Korea adverse event reporting system database.
Young-Jin KoSeonji KimKyounghoon ParkMinsuk KimBo Ram YangJoongyub LeeMi-Sook KimByung-Joo ParkPublished in: Therapeutic advances in drug safety (2019)
Rivaroxaban might have stronger association with bleeding than apixaban and dabigatran.